The 22nd Annual Winter Lung Cancer Conference, January 31-February 2, 2025, will cover advances in NSCLC and SCLC treatment.

Updated findings from the phase 3 ENGOT-cx11/GOG-3047/KEYNOTE-A18 study (NCT04221945) show the survival advantages of ...

The top stories in non-small cell lung cancer (NSCLC) for 2024 included practice-changing results in EGFR-mutant disease, an ...

The partners are also studying their personalized vaccine with Keytruda as an adjuvant NSCLC treatment for those who haven't gotten neoadjuvant therapy.

In this article, we use the example of head and neck cancer to show how concurrent chemoradiotherapy is used to treat a cancer where locoregional control is central for treatment success.

While surgery is the primary treatment approach, neoadjuvant and adjuvant therapies play crucial roles in enhancing the prognosis of patients undergoing treatment with the goal of cure. In this study, ...

The goal in treating ulcerative colitis is to reduce the inflammation, hopefully leading to remission. The two leading treatment options are medication and surgery. Approximately 70 percent of ...

Strengths of INTERLACE include the prospective, randomised, pragmatic design, with quality control for radiation therapy planning, mature data with long follow-up, and inclusion of a well tolerated ...

The treatment consisted of a short course of chemotherapy before patients undergo chemoradiation, the standard treatment for cervical cancer involving a combination of chemotherapy and radiotherapy.

The study investigated the efficacy of a short course of chemotherapy followed by the conventional chemoradiation treatment. This approach was tested over a decade with a diverse group of ...